Clinical management of Staphylococcus aureus bacteremia: a review.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2014.9743PMID 25268440PMCID PMC4263314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

  2014cited by this paper
• The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.

  2014cited by this paper
• Staphylococcus aureus bacteraemia in a UK tertiary referral centre: a 'transoesophageal echocardiogram for all' policy.

  2014cited by this paper
• Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies.

  2014cited by this paper
• Infectious diseases consultation and the management of Staphylococcus aureus bacteremia.

  2014cited by this paper
• Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.

  2014cited by this paper
• A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

  2014cited by this paper
• Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

  2013cited by this paper
• Infection Foci , and Mortality of 342 Patients With Staphyloccocus aureus Bacteremia According to Type of Infectious Disease Specialist Consultation

  2013cited by this paper
• High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis

  2013cited by this paper
• Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.

  2013cited by this paper
• Prioritizing echocardiography in Staphylococcus aureus bacteraemia.

  2013cited by this paper
• Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis

  2013cited by this paper
• The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.

  2013cited by this paper
• Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.

  2013cited by this paper
• Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia.

  2013cited by this paper
• Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.

  2013cited by this paper
• β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

  2013cited by this paper
• Echocardiography Is Dispensable in Uncomplicated Staphylococcus aureus Bacteremia

  2013cited by this paper
• Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?

  2013cited by this paper
• Multicenter Prospective Observational Study of the Comparative Efficacy and Safety of Vancomycin versus Teicoplanin in Patients with Health Care-Associated Methicillin-Resistant Staphylococcus aureus Bacteremia

  2013cited by this paper
• Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

  2012cited by this paper
• Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study

  2012cited by this paper
• Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

  2012cited by this paper
• Predicting Risk for Death from MRSA Bacteremia

  2012cited by this paper
• Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes

  2012cited by this paper
• Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.

  2012cited by this paper
• Predictors of Mortality in Staphylococcus aureus Bacteremia

  2012cited by this paper
• The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

  2012cited by this paper
• Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan

  2012cited by this paper
• Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.

  2012cited by this paper
• Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia

  2012cited by this paper
• Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

  2012cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study

  2011cited by this paper
• Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

  2011cited by this paper
• Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.

  2011cited by this paper
• High‐Dose Daptomycin for Treatment of Complicated Gram‐Positive Infections: A Large, Multicenter, Retrospective Study

  2011cited by this paper
• Is transesophageal echocardiography dispensable in hospital-acquired Staphylococcus aureus bacteremia?

  2011cited by this paper
• Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

  2011cited by this paper
• Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia.

  2011cited by this paper
• Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool

  2011cited by this paper
• Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

  2011cited by this paper
• Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

  2011cited by this paper
• Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia.

  2011cited by this paper
• Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.

  2010cited by this paper
• Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia.

  2010cited by this paper
• The value of infectious diseases consultation in Staphylococcus aureus bacteremia.

  2010cited by this paper
• Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.

  2010cited by this paper
• Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany.

  2009cited by this paper
• Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

  2009cited by this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study.

  2009cited by this paper
• Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

  2009cited by this paper
• Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

  2009cited by this paper
• Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus Bacteremia

  2009cited by this paper
• Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

  2009cited by this paper
• The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

  2009cited by this paper
• The Potential Impact of Contemporary Transthoracic Echocardiography on the Management of Patients with Native Valve Endocarditis: A Comparison with Transesophageal Echocardiography

  2009cited by this paper
• Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.

  2009cited by this paper
• Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.

  2008cited by this paper
• Allergy diagnostic testing: an updated practice parameter.

  2008cited by this paper
• Allergy diagnostic testing

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

  2007cited by this paper
• Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

  2007cited by this paper
• Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence.

  2007cited by this paper
• Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia

  2007cited by this paper
• Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy

  2007cited by this paper
• Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

  2006cited by this paper
• Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia

  2006cited by this paper
• Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.

  2006cited by this paper
• Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.

  2005cited by this paper
• Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study

  2005cited by this paper
• The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia.

  2005cited by this paper
• Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia.

  2005cited by this paper
• Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.

  2005cited by this paper
• Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.

  2005cited by this paper
• Staphylococcus aureus endocarditis: a consequence of medical progress.

  2005cited by this paper
• Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

  2003cited by this paper
• Staphylococcus aureus Bacteremia: Recurrence and the Impact of Antibiotic Treatment in a Prospective Multicenter Study

  2003cited by this paper
• Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.

  2003cited by this paper
• Clinical identifiers of complicated Staphylococcus aureus bacteremia.

  2003cited by this paper
• Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

  2000cited by this paper
• Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin–dalfopristin in patients intolerant of or failing prior therapy

  2000cited by this paper
• Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

  2000cited by this paper
• Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.

  1999cited by this paper
• Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia

  1999cited by this paper
• Questionable history of immediate-type hypersensitivity to penicillin in Staphylococcal endocarditis: treatment based on skin-test results vers-us empirical alternative treatment--A decision analysis.

  1999cited by this paper
• Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

  1998cited by this paper
• Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients.

  1997cited by this paper
• Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.

  1996cited by this paper
• New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

  1994cited by this paper
• Transesophageal echocardiography.

  1994cited by this paper
• Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program

  1994cited by this paper
• Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia

  1993cited by this paper
• Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection

  1992cited by this paper
• Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.

  1991cited by this paper
• Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.

  1989cited by this paper
• Staphylococcus aureus bacteraemia

  1984cited by this paper

• Clinical relevance of follow-up blood cultures in patients with Streptococcus and Enterococcus species bacteremia.

  2026cites this paper
• Rapid Clearance of Refractory Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia With Septic Pulmonary Emboli Following Early Ceftaroline Therapy

  2026influential citation
• Drug-caged drugs enable photocatalytic dual decaging of nitric oxide and anesthetics for antibacterial analgesia.

  2026cites this paper
• Iliopsoas Abscess: A Narrative Review.

  2026cites this paper
• Rapid Diagnosis of Bacteremia in Febrile Pediatric Oncology Patients via Host-Response Infrared Spectroscopy of Blood and Machine Learning.

  2026cites this paper
• Methicillin-Sensitive Staphylococcus aureus Bacteremia, Septic Arthritis, and Pyomyositis in a Young Male: A Case Report and Review of the Literature

  2025cites this paper
• Optimal Vancomycin AUC Target in Pediatric MRSA Bacteremia: A Bayesian-guided Approach

  2025cites this paper
• Effectiveness of Vascular Catheter Removal Versus Retention in Non-ICU Patients with CRBSI or CABSI in Retrospective, Single-Center Study

  2025cites this paper
• Antimicrobial, Anti-inflammatory, Angiogenesis, and Wound Healing Activities of Copper Nanoparticles Green Synthesized by Lupinus arcticus Extract

  2025cites this paper
• Community-Acquired Vancomycin-Resistant Staphylococcus aureus Mitral Valve Endocarditis with Cerebral Embolization in an Immunocompetent Young Adult: A Case Report and Literature Review

  2025cites this paper
• A Tailored Artificial Biocatalyst for Bacterial Endophthalmitis Therapy via Enhanced Ferroptosis‐Like Death

  2025cites this paper
• Efficacy and safety of earlier switching to an oral antibiotic therapy for the treatment of Gram-positive bloodstream infections: a systematic review and meta-analysis.

  2025cites this paper
• Global insights into MRSA bacteremia: a bibliometric analysis and future outlook

  2025cites this paper
• Repurposing Diflunisal as an Antivirulence Agent Against Staphylococcus aureus

  2025cites this paper
• A comparative analysis between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia

  2025cites this paper
• Matrine alleviates Staphylococcus aureus-induced acute lung injury in mice by inhibiting MLKL and NLRP3-mediated inflammatory activity.

  2025cites this paper
• Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment

  2025cites this paper
• Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia

  2025cites this paper
• Management of methicillin-resistant Staphylococcus aureus bloodstream infections: a comprehensive narrative review of available evidence focusing on current controversies and the challenges ahead

  2025cites this paper
• Prostatic abscesses as a cause of persistent Staphylococcus aureus bacteremia.

  2025cites this paper
• Bacterial Profile and Antimicrobial Susceptibility Pattern in Community-acquired Pneumonia patient at General Hospital, Indonesia

  2025cites this paper
• Combination therapy with fosfomycin for Staphylococcus aureus bacteraemia or endocarditis: a systematic review and meta-analysis of randomized trials

  2025cites this paper
• Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial.

  2025cites this paper
• Increasing evidence-based care practices for patients with Staphylococcus aureus bacteraemia through required infectious diseases consultation in a tertiary care hospital: a quality improvement initiative

  2025cites this paper
• Synthetic Cation Transporters Eradicate Drug-Resistant Staphylococcus aureus, Persisters, and Biofilms

  2025cites this paper
• Management of Staphylococcus aureus Bacteremia: A Review.

  2025cites this paper
• Impact of an Algorithm to Triage Patients Discharged From the Emergency Department With Blood Cultures Positive for Staphylococcus aureus or Coagulase-Negative Staphylococcus

  2025influential citation
• Effective Management of a Skin and Soft Tissue Infection Caused by Community-Acquired MRSA Through Triple-Targeted Therapy Along with Aggressive Source Control: A Case Report

  2025cites this paper
• Navigating the Challenges in Staphylococcus aureus Bloodstream Infection: A Practical Guide to Management.

  2025cites this paper
• Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections

  2025cites this paper
• Significant Publications on Infectious Diseases Pharmacotherapy in 2024.

  2025cites this paper
• Management and Outcome of Invasive Clindamycin-Resistant MRSA Community-Associated Infections in Children

  2025cites this paper
• Real-time multimodal imaging of daptomycin action on the cell wall of adherent Staphylococcus aureus

  2025cites this paper
• Toward defining complicated coagulase-negative staphylococcal bacteremia.

  2025cites this paper
• Uncomplicated Staphylococcus aureus bacteraemia: Partial oral treatment is comparable to fully intravenous treatment – A single center retrospective cohort study

  2024cites this paper
• The Prevalence, Epidemiological, and Molecular Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) in Macau (2017–2022)

  2024cites this paper
• Substance use disorder-associated infections’ treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) – an investigator-initiated single-arm unblinded prospective cohort study

  2024cites this paper
• Impact of [18F] FDG PET/CT on outcomes in patients with Staphylococcus aureus bacteremia: A retrospective single-center experience.

  2024cites this paper
• Infective Endocarditis in Patients Receiving Hemodialysis: A Current Review

  2024cites this paper
• Pharmacist-led antimicrobial stewardship program in the treatment of Staphylococcus aureus bacteraemia in paediatric patients: a multivariate analysis

  2024cites this paper
• 79-Year-Old Man With Dysuria, Fever, and Back Pain.

  2024cites this paper
• Comparison of the 2015 and 2023 Duke–European Society of Cardiology Criteria Among Patients With Suspected Infective Endocarditis

  2024cites this paper
• The Utilization Of Echocardiography In Children With Staphylococcus aureus Bacteremia.

  2024cites this paper
• Determining the Antibiotic Resistance of Staphylococcus aureus Strains Isolated from Patients Hospitalized in Zahedan, Southeastern Iran

  2024cites this paper
• Current management of Staphylococcus aureus bacteremia in a Japanese university hospital

  2024cites this paper
• Assessing the Interpretation of Molecular Test Results in the Diagnosis of Bloodstream Infections

  2024cites this paper
• Utility of Echocardiogram in Neutropenic Patients with Gram-Positive Bacteremia: A Retrospective Study

  2024cites this paper
• Native Infective Endocarditis: A State-of-the-Art-Review

  2024cites this paper
• A “three-in-one” multifunctional palladium/platinum nanoparticles-driven multimodal lateral flow immunoassays for point-of-care testing of Staphylococcus aureus

  2024cites this paper
• Molecular epidemiology and clinical characteristics of Staphylococcus aureus bacteremia in Japanese adults.

  2024cites this paper
• Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017–2020

  2024cites this paper
• Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infections: Results From a Large United States Claims Database

  2024cites this paper
• Quantifying how much host, pathogen, and other factors affect human protective adaptive immune responses

  2024cites this paper
• Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis

  2024cites this paper
• Adherence to and clinical utility of “quality indicators” for Staphylococcus aureus bacteremia: a retrospective, multicenter study

  2024cites this paper
• Comparative in vitro efficacy of antibiotics against the intracellular reservoir of Staphylococcus aureus.

  2024cites this paper
• Time to Staphylococcus aureus Blood Culture Positivity as a Risk Marker of Infective Endocarditis: A Retrospective Cohort Study

  2024cites this paper
• Clinical Implications of the Skip Phenomenon in Patients with Persistent Staphylococcus aureus Bacteremia

  2024cites this paper
• Cold Plasma Activity Against Biofilm Formation of Prosthetic Joint Infection Pathogens

  2024cites this paper
• Validation of a new risk stratification system-based management for methicillin-resistant Staphylococcus aureus bacteraemia: analysis of a multicentre prospective study

  2024cites this paper
• Staphylococcus aureus Dissemination Presenting With Encephalopathy and Epidural Abscess

  2024cites this paper
• SEMI-SOLID EXTRUSION 3D-PRINTING OF EUCALYPT EXTRACT-LOADED POLYETHYLENE OXIDE GELS INTENDED FOR PHARMACEUTICAL APPLICATIONS

  2023cites this paper
• Convergent Replication and Mobilization Mechanism of Staphylococcus Pathogenicity Islands (SaPIbov5) by Interfering with Bacteriophage 12 Production Models

  2023cites this paper
• Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia.

  2023cites this paper
• Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study

  2023cites this paper
• The Occurrence of Methicillin-Resistant Staphylococcus Aureus (MRSA) Around the World and Antibiotic Therapy for Selected Infections Caused By MRSA

  2023cites this paper
• Impact of the COVID-19 Pandemic on the Management of Staphylococcus aureus Bloodstream Infections in a Tertiary Care Hospital

  2023cites this paper
• Efficacy and Safety of Vancomycin for the Treatment of Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.

  2023cites this paper
• A Retrospective Study of Staphylococcus aureus Bacteremia in a Tertiary Hospital and Factors Associated with Mortality

  2023cites this paper
• Bacteremia with gram positive bacteria - when and how do I need to look for endocarditis?

  2023cites this paper
• Impact of specialty on the self-reported practice of using oral antibiotic therapy for definitive treatment of bloodstream infections

  2023cites this paper
• Acetylenic spiroketal enol ethers from Artemisia rupestris and their synergistic antibacterial effects on methicillin-resistant Staphylococcus aureus

  2023cites this paper
• Evaluation of Clinical Approach and Outcomes Staphylococcus aureus Bacteremia

  2023cites this paper
• Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteremia. A propensity-matched cohort analysis.

  2023cites this paper
• Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia.

  2023cites this paper
• Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment

  2023cites this paper
• Emerging Strategies to Combat Methicillin-Resistant Staphylococcus aureus (MRSA): Natural Agents with High Potential.

  2023cites this paper
• A fatal case of persistent bacteremia and acute cholecystitis caused by Staphylococcus aureus: A case report

  2023influential citation
• Staphylococcus aureus bacteremia treatment outcomes in patients receiving ticagrelor versus a propensity-matched cohort receiving clopidogrel.

  2023cites this paper
• PHARMACEUTICAL 3D-PRINTING OF NANOEMULSIFIED EUCALYPT EXTRACTS AND THEIR ANTIMICROBIAL ACTIVITY.

  2023cites this paper
• Time-lapse proteomics unveil constant high exposure of non-antibiotic drug induces synthetic susceptibility towards regular antibiotics.

  2023cites this paper
• Impact of Early Chemotherapy Resumption on the Outcome after Staphylococcus aureus Bacteremia in Patients with Solid Tumors: A Retrospective Study in a Single Tertiary Cancer Center in Japan

  2023cites this paper
• The Next Generation: Mentoring and Diversity in the Antibacterial Resistance Leadership Group.

  2023cites this paper
• Sorbus Aucuparia L. Fruit Extract and its Cosmetics – As Promising Agents for Prophylactic and Treatment of Pyodermitis: Phytochemical and Microbiological Research

  2023cites this paper
• The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence

  2023cites this paper
• Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus

  2023cites this paper
• Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections

  2023cites this paper
• Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.

  2023cites this paper
• Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.

  2023cites this paper
• The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management

  2023cites this paper
• Measuring beta-lactam minimum inhibitory concentrations in Staphylococcus aureus in the clinical microbiology laboratory: pinning the tail on the donkey

  2023cites this paper
• Clinical reasoning for performance of transesophageal echocardiography in veterans with Staphylococcus aureus bacteremia

  2023cites this paper
• Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis.

  2022cites this paper
• Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus: A Systematic Review and Meta-Analysis

  2022cites this paper
• Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis

  2022cites this paper
• Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis

  2022cites this paper
• Complicated and uncomplicated S. aureus bacteremia: an international Delphi survey among infectious diseases experts on definitions and treatment.

  2022cites this paper
• Varón de 71 años hipertenso, diabético, con insuficiencia renal crónica, marcapasos y TAVI que acude por fiebre

  2022cites this paper
• Clindamycin Efficacy in Patients With Methicillin-Sensitive Staphylococcus aureus in a Fourth-Level Hospital in the City of Medellín

  2022influential citation
• Achieving Ultrasensitive Chromogenic Probes for Rapid, Direct Detection of Carbapenemase-Producing Bacteria in Sputum

  2022cites this paper